{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:44:25Z","timestamp":1792100665391,"version":"4.4.0"},"reference-count":195,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-026-02808-1","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:10:08Z","timestamp":1791987008000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["It takes two to tango: the intersection of deubiquitinases and m6A modification in cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Xuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haolong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuyan","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"issue":"1","key":"2808_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1059.","journal-title":"Cancer Discov"},{"issue":"5","key":"2808_CR2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013.","journal-title":"Cell"},{"key":"2808_CR3","doi-asserted-by":"publisher","first-page":"101173","DOI":"10.1016\/j.drup.2024.101173","volume":"78","author":"C Miao","year":"2025","unstructured":"Miao C, Huang Y, Zhang C, Wang X, Wang B, Zhou X, et al. Post-translational modifications in drug resistance. Drug Resist Updat. 2025;78:101173. https:\/\/doi.org\/10.1016\/j.drup.2024.101173.","journal-title":"Drug Resist Updat"},{"key":"2808_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.gde.2017.10.006","volume":"48","author":"RF Harvey","year":"2018","unstructured":"Harvey RF, Willis AE. Post-transcriptional control of stress responses in cancer. Curr Opin Genet Dev. 2018;48:30\u201335. https:\/\/doi.org\/10.1016\/j.gde.2017.10.006.","journal-title":"Curr Opin Genet Dev"},{"issue":"1","key":"2808_CR5","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12943-023-01810-1","volume":"22","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wang Y, Patel H, Chen J, Wang J, Chen ZS, et al. Epigenetic modification of m6A regulator proteins in cancer. Mol Cancer. 2023;22(1):102. https:\/\/doi.org\/10.1186\/s12943-023-01810-1.","journal-title":"Mol Cancer"},{"issue":"1","key":"2808_CR6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12943-022-01704-8","volume":"22","author":"X Cao","year":"2023","unstructured":"Cao X, Geng Q, Fan D, Wang Q, Wang X, Zhang M, et al. m6A methylation: a process reshaping the tumour immune microenvironment and regulating immune evasion. Mol Cancer. 2023;22(1):42. https:\/\/doi.org\/10.1186\/s12943-022-01704-8.","journal-title":"Mol Cancer"},{"issue":"1","key":"2808_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrd.2017.152","volume":"17","author":"JA Harrigan","year":"2018","unstructured":"Harrigan JA, Jacq X, Martin NM, Jackson SP. Deubiquitylating enzymes and drug discovery: emerging opportunities. Nat Rev Drug Discov. 2018;17(1):57\u201378. https:\/\/doi.org\/10.1038\/nrd.2017.152.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"2808_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nrm.2016.132","volume":"18","author":"BS Zhao","year":"2017","unstructured":"Zhao BS, Roundtree IA, He C. Post-transcriptional gene regulation by mRNA modifications. Nat Rev Mol Cell Biol. 2017;18(1):31\u201342. https:\/\/doi.org\/10.1038\/nrm.2016.132.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"2808_CR9","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1158\/0008-5472.CAN-18-2965","volume":"79","author":"Q Lan","year":"2019","unstructured":"Lan Q, Liu PY, Haase J, Bell JL, H\u00fcttelmaier S, Liu T. The critical role of RNA m6A methylation in cancer. Cancer Res. 2019;79(7):1285\u201392. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-2965.","journal-title":"Cancer Res"},{"issue":"1","key":"2808_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12943-021-01356-0","volume":"20","author":"MB Uddin","year":"2021","unstructured":"Uddin MB, Wang Z, Yang C. The m6A RNA methylation regulates oncogenic signaling pathways driving cell malignant transformation and carcinogenesis. Mol Cancer. 2021;20(1):61. https:\/\/doi.org\/10.1186\/s12943-021-01356-0.","journal-title":"Mol Cancer"},{"issue":"1","key":"2808_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12943-024-02046-3","volume":"23","author":"F Liu","year":"2024","unstructured":"Liu F, Chen J, Li K, Li H, Zhu Y, Zhai Y, et al. Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches. Mol Cancer. 2024;23(1):148. https:\/\/doi.org\/10.1186\/s12943-024-02046-3.","journal-title":"Mol Cancer"},{"key":"2808_CR12","doi-asserted-by":"publisher","unstructured":"Ren J, Yu P, Liu S, Li R, Niu X, Chen Y, et al. Deubiquitylating enzymes in cancer and immunity. Adv Sci (Weinh). 2023;10(36):e2303807. https:\/\/doi.org\/10.1002\/advs.202303807.","DOI":"10.1002\/advs.202303807"},{"issue":"12","key":"2808_CR13","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41568-023-00633-y","volume":"23","author":"G Dewson","year":"2023","unstructured":"Dewson G, Eichhorn P, Komander D. Deubiquitinases in cancer. Nat Rev Cancer. 2023;23(12):842\u201362. https:\/\/doi.org\/10.1038\/s41568-023-00633-y.","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"2808_CR14","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.7150\/ijbs.111867","volume":"21","author":"SK Hsu","year":"2025","unstructured":"Hsu SK, Kuo IY, Lin PY, Chou CK, Ko CC, Chang WT, et al. Deubiquitinating enzymes: key regulators of ferroptosis and pyroptosis and novel targets for cancer intervention. Int J Biol Sci. 2025;21(9):3993\u20134009. https:\/\/doi.org\/10.7150\/ijbs.111867.","journal-title":"Int J Biol Sci"},{"issue":"9","key":"2808_CR15","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/cac2.70044","volume":"45","author":"S Zhu","year":"2025","unstructured":"Zhu S, Zhang X, Liu W, Zhou Z, Xiong S, Li J, et al. Ubiquitination in cancer: mechanisms and therapeutic opportunities. Cancer Commun (Lond). 2025;45(9):1128\u201361. https:\/\/doi.org\/10.1002\/cac2.70044.","journal-title":"Cancer Commun (Lond)"},{"key":"2808_CR16","doi-asserted-by":"publisher","first-page":"107815","DOI":"10.1016\/j.phrs.2025.107815","volume":"217","author":"YX Yan","year":"2025","unstructured":"Yan YX, Zhou HM, Shang XG, Xu P, Tang XQ, Zheng XY, et al. Dynamic regulators of ferroptosis: post-translational modifications in ferroptotic cell death. Pharmacol Res. 2025;217:107815. https:\/\/doi.org\/10.1016\/j.phrs.2025.107815.","journal-title":"Pharmacol Res"},{"key":"2808_CR17","doi-asserted-by":"publisher","first-page":"152914","DOI":"10.1016\/j.bbrc.2025.152914","volume":"790","author":"L Li","year":"2025","unstructured":"Li L, Gu X, Zhang T. Deubiquitinases in DNA damage repair: implication and mechanism in cancer. Biochem Biophys Res Commun. 2025;790:152914. https:\/\/doi.org\/10.1016\/j.bbrc.2025.152914.","journal-title":"Biochem Biophys Res Commun"},{"key":"2808_CR18","doi-asserted-by":"publisher","unstructured":"Murali P, Kavitha B, Narasimhan M. Deubiquitinases and cancer. J Pharm Bioallied Sci. 2024;16(Suppl 5):SS4210\u2013S4220. https:\/\/doi.org\/10.4103\/jpbs.jpbs_517_24.","DOI":"10.4103\/jpbs.jpbs_517_24"},{"issue":"11","key":"2808_CR19","doi-asserted-by":"publisher","first-page":"4811","DOI":"10.62347\/JIAR9649","volume":"15","author":"S Yu","year":"2025","unstructured":"Yu S, et al. OTU deubiquitinases in cancer pathogenesis and precision therapy. Am J Cancer Res. 2025;15(11):4811\u201344. https:\/\/doi.org\/10.62347\/JIAR9649.","journal-title":"Am J Cancer Res"},{"key":"2808_CR20","doi-asserted-by":"publisher","unstructured":"Deng Y, Liu P. OTU deubiquitinases in disease: roles and targeting. Trends Mol Med. 2025;32(1):S84\u201397 [pii]. https:\/\/doi.org\/10.1016\/j.molmed.2025.05.006.","DOI":"10.1016\/j.molmed.2025.05.006"},{"issue":"4","key":"2808_CR21","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.molcel.2020.10.026","volume":"80","author":"HL Sun","year":"2020","unstructured":"Sun HL, Zhu AC, Gao Y, Terajima H, Fei Q, Liu S, et al. Stabilization of ERK-Phosphorylated METTL3 by USP5 increases m6A methylation. Mol Cell. 2020;80(4):633\u201347.e7. https:\/\/doi.org\/10.1016\/j.molcel.2020.10.026.","journal-title":"Mol Cell"},{"issue":"4","key":"2808_CR22","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1093\/neuonc\/noae268","volume":"27","author":"J Qiu","year":"2025","unstructured":"Qiu J, Zhao R, Ma C, Wang Q, Li B, Qi Y, et al. O-GlcNAcylation stabilized WTAP promotes GBM malignant progression in an N6-methyladenosine-dependent manner. Neuro Oncol. 2025;27(4):900\u201315. https:\/\/doi.org\/10.1093\/neuonc\/noae268.","journal-title":"Neuro Oncol"},{"issue":"16","key":"2808_CR23","doi-asserted-by":"publisher","first-page":"7640","DOI":"10.7150\/thno.61178","volume":"11","author":"Y Chen","year":"2021","unstructured":"Chen Y, Pan C, Wang X, Xu D, Ma Y, Hu J, et al. Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells. Theranostics. 2021;11(16):7640\u201357. https:\/\/doi.org\/10.7150\/thno.61178.","journal-title":"Theranostics"},{"issue":"12","key":"2808_CR24","first-page":"13423","volume":"13","author":"Y Li","year":"2021","unstructured":"Li Y, Cheng X, Chen Y, Zhou T, Li D, Zheng WV. METTL3 facilitates the progression of hepatocellular carcinoma by modulating the m6A level of USP7. Am J Transl Res. 2021;13(12):13423\u201337.","journal-title":"Am J Transl Res"},{"key":"2808_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/6167832","volume":"2022","author":"D Yuan","year":"2022","unstructured":"Yuan D, Chen J, Hao Q, Zhang P, Chen Z. Methyltransferase-like 3 aggravates HCC development via mediating N6-methyladenosine of ubiquitin-specific protease 7. J Oncol. 2022:1\u20139. https:\/\/doi.org\/10.1155\/2022\/6167832.","journal-title":"J Oncol"},{"key":"2808_CR26","doi-asserted-by":"publisher","first-page":"647702","DOI":"10.3389\/fcell.2021.647702","volume":"9","author":"XY Chen","year":"2021","unstructured":"Chen XY, Liang R, Yi YC, Fan HN, Chen M, Zhang J, et al. The m6A Reader YTHDF1 facilitates the Tumorigenesis and metastasis of gastric cancer via USP14 translation in an m6A-Dependent manner. Front Cell Dev Biol. 2021;9:647702. https:\/\/doi.org\/10.3389\/fcell.2021.647702.","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"2808_CR27","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s10753-024-02097-0","volume":"48","author":"J Lan","year":"2025","unstructured":"Lan J, Huang X, Li H, Lin S, Huang J, Yang W, et al. YTHDF2 regulates advanced glycation end products-induced melanogenesis through inhibiting A20 expression in human dermal fibroblasts. Inflammation. 2025;48(2):919\u201334. https:\/\/doi.org\/10.1007\/s10753-024-02097-0.","journal-title":"Inflammation"},{"issue":"7","key":"2808_CR28","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.7150\/ijbs.82081","volume":"19","author":"C Wang","year":"2023","unstructured":"Wang C, Meng Y, Zhao J, Ma J, Zhao Y, Gao R, et al. Deubiquitinase USP13 regulates glycolytic reprogramming and progression in osteosarcoma by stabilizing METTL3\/m 6 A\/ATG5 axis. Int J Biol Sci. 2023;19(7):2289\u2013303. https:\/\/doi.org\/10.7150\/ijbs.82081.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"2808_CR29","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s13046-023-02792-0","volume":"42","author":"K Lin","year":"2023","unstructured":"Lin K, Zhou E, Shi T, Zhang S, Zhang J, Zheng Z, et al. m6A eraser FTO impairs gemcitabine resistance in pancreatic cancer through influencing NEDD4 mRNA stability by regulating the PTEN\/PI3K\/AKT pathway. J Exp Clin Cancer Res. 2023;42(1):217. https:\/\/doi.org\/10.1186\/s13046-023-02792-0.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"2808_CR30","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/ncb3358","volume":"18","author":"R Yau","year":"2016","unstructured":"Yau R, Rape M. The increasing complexity of the ubiquitin code. Nat Cell Biol. 2016;18(6):579\u201386. https:\/\/doi.org\/10.1038\/ncb3358.","journal-title":"Nat Cell Biol"},{"issue":"7","key":"2808_CR31","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.tcb.2015.03.002","volume":"25","author":"MJ Clague","year":"2015","unstructured":"Clague MJ, Heride C, Urb\u00e9 S. The demographics of the ubiquitin system. Trends Cell Biol. 2015;25(7):417\u201326. https:\/\/doi.org\/10.1016\/j.tcb.2015.03.002.","journal-title":"Trends Cell Biol"},{"issue":"6","key":"2808_CR32","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41580-019-0099-1","volume":"20","author":"MJ Clague","year":"2019","unstructured":"Clague MJ, Urb\u00e9 S, Komander D. Breaking the chains: deubiquitylating enzyme specificity begets function. Nat Rev Mol Cell Biol. 2019;20(6):338\u201352. https:\/\/doi.org\/10.1038\/s41580-019-0099-1.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"2808_CR33","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1146\/annurev.physiol.59.1.63","volume":"59","author":"HA Chapman","year":"1997","unstructured":"Chapman HA, Riese RJ, Shi GP. Emerging roles for cysteine proteases in human biology. Annu Rev Physiol. 1997;59(1):63\u201388. https:\/\/doi.org\/10.1146\/annurev.physiol.59.1.63.","journal-title":"Annu Rev Physiol"},{"key":"2808_CR34","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/978-1-4419-6676-6_6","volume":"54","author":"D Komander","year":"2010","unstructured":"Komander D. Mechanism, specificity and structure of the deubiquitinases. Subcell Biochem. 2010;54:69\u201387.","journal-title":"Subcell Biochem"},{"issue":"1","key":"2808_CR35","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.molcel.2016.05.042","volume":"63","author":"CW Pak","year":"2016","unstructured":"Pak CW, Kosno M, Holehouse AS, Padrick SB, Mittal A, Ali R, et al. Sequence determinants of intracellular phase separation by complex coacervation of a disordered protein. Mol Cell. 2016;63(1):72\u201385. https:\/\/doi.org\/10.1016\/j.molcel.2016.05.042.","journal-title":"Mol Cell"},{"issue":"3","key":"2808_CR36","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1152\/physrev.00002.2013","volume":"93","author":"MJ Clague","year":"2013","unstructured":"Clague MJ, Barsukov I, Coulson JM, Liu H, Rigden DJ, Urb\u00e9 S. Deubiquitylases from genes to organism. Physiol Rev. 2013;93(3):1289\u2013315. https:\/\/doi.org\/10.1152\/physrev.00002.2013.","journal-title":"Physiol Rev"},{"issue":"40","key":"2808_CR37","doi-asserted-by":"publisher","first-page":"30982","DOI":"10.1074\/jbc.M110.135392","volume":"285","author":"L Feng","year":"2010","unstructured":"Feng L, Wang J, Chen J. The Lys63-specific deubiquitinating enzyme BRCC36 is regulated by two scaffold proteins localizing in different subcellular compartments. J Biol Chem. 2010;285(40):30982\u201388. https:\/\/doi.org\/10.1074\/jbc.M110.135392.","journal-title":"J Biol Chem"},{"issue":"24","key":"2808_CR38","doi-asserted-by":"publisher","first-page":"17145","DOI":"10.1074\/jbc.M113.463406","volume":"288","author":"T Seki","year":"2013","unstructured":"Seki T, Gong L, Williams AJ, Sakai N, Todi SV, Paulson HL. JosD1, a membrane-targeted Deubiquitinating enzyme, is activated by ubiquitination and regulates membrane dynamics, cell motility, and endocytosis. J Biol Chem. 2013;288(24):17145\u201355. https:\/\/doi.org\/10.1074\/jbc.M113.463406.","journal-title":"J Biol Chem"},{"issue":"1","key":"2808_CR39","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejcb.2018.10.003","volume":"98","author":"A Olazabal-Herrero","year":"2019","unstructured":"Olazabal-Herrero A, Sendino M, Arganda-Carreras I, Rodr\u00edguez JA. WDR20 regulates shuttling of the USP12 deubiquitinase complex between the plasma membrane, cytoplasm and nucleus. Eur J Cell Biol. 2019;98(1):12\u201326. https:\/\/doi.org\/10.1016\/j.ejcb.2018.10.003.","journal-title":"Eur J Cell Biol"},{"issue":"12","key":"2808_CR40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/mco2.70036","volume":"5","author":"Y Xian","year":"2020","unstructured":"Xian Y, Ye J, Tang Y, Zhang N, Peng C, Huang W, et al. Deubiquitinases as novel therapeutic targets for diseases. MedComm. 2020;5(12):5. https:\/\/doi.org\/10.1002\/mco2.70036.","journal-title":"MedComm"},{"issue":"6","key":"2808_CR41","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.cell.2013.05.014","volume":"153","author":"K Keusekotten","year":"2013","unstructured":"Keusekotten K, Elliott PR, Glockner L, et al. OTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitin. Cell. 2013;153(6):1312\u201326. https:\/\/doi.org\/10.1016\/j.cell.2013.05.014.","journal-title":"Cell"},{"issue":"1","key":"2808_CR42","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12943-024-02005-y","volume":"23","author":"H Gao","year":"2024","unstructured":"Gao H, Xi Z, Dai J, Xue J, Guan X, Zhao L, et al. Drug resistance mechanisms and treatment strategies mediated by Ubiquitin-specific proteases (USPs) in cancers: new directions and therapeutic options. Mol Cancer. 2024;23(1):88. https:\/\/doi.org\/10.1186\/s12943-024-02005-y.","journal-title":"Mol Cancer"},{"issue":"4","key":"2808_CR43","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/ncb1378","volume":"8","author":"TT Huang","year":"2006","unstructured":"Huang TT, Nijman SM, Mirchandani KD, et al. Regulation of monoubiquitinated PCNA by DUB autocleavage. Nat Cell Biol. 2006;8(4):341\u201347. https:\/\/doi.org\/10.1038\/ncb1378.","journal-title":"Nat Cell Biol"},{"issue":"11","key":"2808_CR44","doi-asserted-by":"publisher","first-page":"6273","DOI":"10.1073\/pnas.96.11.6273","volume":"96","author":"C Liu","year":"1999","unstructured":"Liu C, Kato Y, Zhang Z, Do VM, Yankner BA, He X. \u03b2-Trcp couples \u03b2-catenin phosphorylation-degradation and regulates Xenopus axis formation. Proc Natl Acad Sci U S A. 1999;96(11):6273\u201378. https:\/\/doi.org\/10.1073\/pnas.96.11.6273.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2808_CR45","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1016\/j.molonc.2015.06.006","volume":"9","author":"SI Yun","year":"2015","unstructured":"Yun SI, Kim HH, Yoon JH, et al. Ubiquitin specific protease 4 positively regulates the WNT\/\u03b2-catenin signaling in colorectal cancer. Mol Oncol. 2015;9(9):1834\u201351. https:\/\/doi.org\/10.1016\/j.molonc.2015.06.006.","journal-title":"Mol Oncol"},{"issue":"25","key":"2808_CR46","doi-asserted-by":"publisher","first-page":"9844","DOI":"10.1074\/jbc.RA119.007655","volume":"294","author":"Z Shang","year":"2019","unstructured":"Shang Z, Zhao J, Zhang Q, et al. USP9X-mediated deubiquitination of B-cell CLL\/lymphoma 9 potentiates wnt signaling and promotes breast carcinogenesis. J Biol Chem. 2019;294(25):9844\u201357.","journal-title":"J Biol Chem"},{"issue":"38","key":"2808_CR47","doi-asserted-by":"publisher","first-page":"35847","DOI":"10.1074\/jbc.M103992200","volume":"276","author":"C Oberg","year":"2001","unstructured":"Oberg C, Li J, Pauley A, Wolf E, Gurney M, Lendahl U. The notch intracellular domain is ubiquitinated and negatively regulated by the mammalian sel-10 homolog. J Biol Chem. 2001;276(38):35847\u201353. https:\/\/doi.org\/10.1074\/jbc.M103992200.","journal-title":"J Biol Chem"},{"issue":"1","key":"2808_CR48","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41392-018-0028-3","volume":"3","author":"H Shan","year":"2018","unstructured":"Shan H, Li X, Xiao X, Dai Y, Huang J, Song J, et al. USP7 deubiquitinates and stabilizes NOTCH1 in T-cell acute lymphoblastic leukemia. Sig Transduct Target Ther. 2018;3(1):29. https:\/\/doi.org\/10.1038\/s41392-018-0028-3.","journal-title":"Sig Transduct Target Ther"},{"issue":"3","key":"2808_CR49","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nm.2619","volume":"18","author":"PJ Eichhorn","year":"2012","unstructured":"Eichhorn PJ, Rod\u00f3n L, Gonz\u00e0lez-Junc\u00e0 A, et al. USP15 stabilizes TGF-\u03b2 receptor I and promotes oncogenesis through the activation of TGF-\u03b2 signaling in glioblastoma. Nat Med. 2012;18(3):429\u201335. https:\/\/doi.org\/10.1038\/nm.2619.","journal-title":"Nat Med"},{"key":"2808_CR50","doi-asserted-by":"publisher","unstructured":"Xie F, Zhou X, Li H, et al. USP8 promotes cancer progression and extracellular vesicle-mediated CD8+ T cell exhaustion by deubiquitinating the TGF-\u03b2 receptor T\u03b2RII. Embo J. 2022;41(16). https:\/\/doi.org\/10.15252\/embj.2021108791.","DOI":"10.15252\/embj.2021108791"},{"issue":"18","key":"2808_CR51","doi-asserted-by":"publisher","first-page":"4921","DOI":"10.1158\/0008-5472.CAN-16-3413","volume":"77","author":"A Toloczko","year":"2017","unstructured":"Toloczko A, Guo F, Yuen HF, et al. Deubiquitinating enzyme USP9X suppresses tumor growth via LATS kinase and core components of the hippo pathway. Cancer Res. 2017;77(18):4921\u201333. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-3413.","journal-title":"Cancer Res"},{"issue":"18","key":"2808_CR52","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1038\/s41388-018-0134-2","volume":"37","author":"L Li","year":"2018","unstructured":"Li L, Liu T, Li Y, et al. The deubiquitinase USP9X promotes tumor cell survival and confers chemoresistance through YAP1 stabilization. Oncogene. 2018;37(18):2422\u201331. https:\/\/doi.org\/10.1038\/s41388-018-0134-2.","journal-title":"Oncogene"},{"issue":"1","key":"2808_CR53","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cell.2013.05.046","volume":"154","author":"TE Mevissen","year":"2013","unstructured":"Mevissen TE, Hospenthal MK, Geurink PP, et al. OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis. Cell. 2013;154(1):169\u201384.","journal-title":"Cell"},{"issue":"1","key":"2808_CR54","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1038\/s41467-017-02029-7","volume":"8","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Fan Y, Xie F, et al. Breast cancer metastasis suppressor OTUD1 deubiquitinates SMAD7. Nat Commun. 2017;8(1):2116. https:\/\/doi.org\/10.1038\/s41467-017-02029-7.","journal-title":"Nat Commun"},{"issue":"1","key":"2808_CR55","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1038\/s41467-018-04620-y","volume":"9","author":"F Yao","year":"2018","unstructured":"Yao F, Zhou Z, Kim J, et al. SKP2- and OTUD1-regulated non-proteolytic ubiquitination of YAP promotes YAP nuclear localization and activity. Nat Commun. 2018;9(1):2269. https:\/\/doi.org\/10.1038\/s41467-018-04620-y.","journal-title":"Nat Commun"},{"issue":"48","key":"2808_CR56","doi-asserted-by":"publisher","first-page":"5186","DOI":"10.1038\/s41388-022-02507-3","volume":"41","author":"C Yan","year":"2022","unstructured":"Yan C, Yang H, Su P, Li X, Li Z, Wang D, et al. OTUB1 suppresses Hippo signaling via modulating YAP protein in gastric cancer. Oncogene. 2022;41(48):5186\u201398. https:\/\/doi.org\/10.1038\/s41388-022-02507-3.","journal-title":"Oncogene"},{"issue":"8","key":"2808_CR57","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1158\/0008-5472.CAN-18-3037","volume":"79","author":"T Liu","year":"2019","unstructured":"Liu T, Jiang L, Tavana O, Gu W. The Deubiquitylase OTUB1 mediates Ferroptosis via stabilization of SLC7A11. Cancer Res. 2019;79(8):1913\u201324. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-3037.","journal-title":"Cancer Res"},{"issue":"5","key":"2808_CR58","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.molcel.2020.10.017","volume":"80","author":"KK Deol","year":"2020","unstructured":"Deol KK, Crowe SO, Du J, Bisbee HA, Guenette RG, Strieter ER. Proteasome-bound UCH37\/UCHL5 debranches ubiquitin chains to promote degradation. Mol Cell. 2020;80(5):796\u2013809.e9. https:\/\/doi.org\/10.1016\/j.molcel.2020.10.017.","journal-title":"Mol Cell"},{"issue":"6","key":"2808_CR59","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1158\/1078-0432.CCR-19-1373","volume":"26","author":"S Liu","year":"2020","unstructured":"Liu S, Gonz\u00e1lez-Prieto R, Zhang M, et al. Deubiquitinase activity profiling identifies UCHL1 as a candidate oncoprotein that promotes TGF\u03b2-induced breast cancer metastasis. Clin Cancer Res. 2020;26(6):1460\u201373.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2808_CR60","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/1878-0261.12844","volume":"15","author":"R Deng","year":"2021","unstructured":"Deng R, Guo Y, Li L, et al. BAP1 suppresses prostate cancer progression by deubiquitinating and stabilizing PTEN. Mol Oncol. 2021;15(1):279\u201398.","journal-title":"Mol Oncol"},{"issue":"10","key":"2808_CR61","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","volume":"20","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Shi J, Liu X, et al. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol. 2018;20(10):1181\u201392. https:\/\/doi.org\/10.1038\/s41556-018-0178-0.","journal-title":"Nat Cell Biol"},{"issue":"5","key":"2808_CR62","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.molcel.2017.07.023","volume":"67","author":"EJ Worden","year":"2017","unstructured":"Worden EJ, Dong KC, Martin A. An AAA motor-driven mechanical switch in Rpn11 controls deubiquitination at the 26S proteasome. Mol Cell. 2017;67(5):799\u2013811.e8. https:\/\/doi.org\/10.1016\/j.molcel.2017.07.023.","journal-title":"Mol Cell"},{"issue":"3","key":"2808_CR63","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.molcel.2019.06.002","volume":"75","author":"J Rabl","year":"2019","unstructured":"Rabl J, Bunker RD, Schenk AD, Cavadini S, Gill ME, Abdulrahman W, et al. Structural basis of BRCC36 function in DNA repair and immune regulation. Mol Cell. 2019;75(3):483\u201397.e9. https:\/\/doi.org\/10.1016\/j.molcel.2019.06.002.","journal-title":"Mol Cell"},{"issue":"1","key":"2808_CR64","doi-asserted-by":"publisher","first-page":"8704","DOI":"10.1038\/ncomms9704","volume":"6","author":"B Wang","year":"2015","unstructured":"Wang B, Ma A, Zhang L, Jin W-L, Qian Y, Xu G, et al. POH1 deubiquitylates and stabilizes E2F1 to promote tumour formation. Nat Commun. 2015;6(1):8704. https:\/\/doi.org\/10.1038\/ncomms9704.","journal-title":"Nat Commun"},{"issue":"6","key":"2808_CR65","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.ccell.2016.10.010","volume":"30","author":"SO Lim","year":"2016","unstructured":"Lim SO, Li CW, Xia W, et al. Deubiquitination and stabilization of PD-L1 by CSN5. Cancer Cell. 2016;30(6):925\u201339. https:\/\/doi.org\/10.1016\/j.ccell.2016.10.010.","journal-title":"Cancer Cell"},{"issue":"3","key":"2808_CR66","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/s41418-020-00639-1","volume":"28","author":"L Krassikova","year":"2021","unstructured":"Krassikova L, Zhang B, Nagarajan D, et al. The deubiquitinase JOSD2 is a positive regulator of glucose metabolism. Cell Death Differ. 2021;28(3):1091\u2013109. https:\/\/doi.org\/10.1038\/s41418-020-00639-1.","journal-title":"Cell Death Differ"},{"issue":"1","key":"2808_CR67","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41418-019-0339-0","volume":"27","author":"X Wu","year":"2020","unstructured":"Wu X, Luo Q, Zhao P, et al. JOSD1 inhibits mitochondrial apoptotic signalling to drive acquired chemoresistance in gynaecological cancer by stabilizing MCL1. Cell Death Differ. 2020;27(1):55\u201370. https:\/\/doi.org\/10.1038\/s41418-019-0339-0.","journal-title":"Cell Death Differ"},{"issue":"1","key":"2808_CR68","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.molcel.2016.05.009","volume":"63","author":"SA Abdul Rehman","year":"2016","unstructured":"Abdul Rehman SA, Kristariyanto YA, Choi SY, et al. MINDY-1 is a member of an evolutionarily conserved and structurally distinct new family of deubiquitinating enzymes. Mol Cell. 2016;63(1):146\u201355.","journal-title":"Mol Cell"},{"issue":"1","key":"2808_CR69","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/s12935-021-02095-4","volume":"21","author":"Y Luo","year":"2021","unstructured":"Luo Y, Zhou J, Tang J, et al. MINDY1 promotes bladder cancer progression by stabilizing YAP. Cancer Cell Int. 2021;21(1):395. https:\/\/doi.org\/10.1186\/s12935-021-02095-4.","journal-title":"Cancer Cell Int"},{"issue":"10","key":"2808_CR70","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/s41419-021-04244-z","volume":"12","author":"J Tang","year":"2021","unstructured":"Tang J, Luo Y, Long G, Zhou L. MINDY1 promotes breast cancer cell proliferation by stabilizing estrogen receptor \u03b1. Cell Death Dis. 2021;12(10):937. https:\/\/doi.org\/10.1038\/s41419-021-04244-z.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2808_CR71","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.molcel.2018.02.023","volume":"70","author":"D Kwasna","year":"2018","unstructured":"Kwasna D, Abdul Rehman SA, Natarajan J, et al. Discovery and characterization of ZUFSP\/ZUP1, a distinct deubiquitinase class important for genome stability. Mol Cell. 2018;70(1):150\u201364.e6. https:\/\/doi.org\/10.1016\/j.molcel.2018.02.023.","journal-title":"Mol Cell"},{"key":"2808_CR72","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jare.2025.11.038","volume":"86","author":"S Huang","year":"2026","unstructured":"Huang S, Qiu Y, Wu L, et al. ZUP1 promotes DNA repair and immune evasion to drive olaparib resistance in triple-negative breast cancer. J Adv Res. 2026;86:363\u201380.","journal-title":"J Adv Res"},{"issue":"25","key":"2808_CR73","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1038\/s41388-018-0200-9","volume":"37","author":"YT Oh","year":"2018","unstructured":"Oh YT, Qian G, Deng J, Sun SY. Monocyte chemotactic protein-induced protein-1 enhances DR5 degradation and negatively regulates DR5 activation-induced apoptosis through its deubiquitinase function. Oncogene. 2018;37(25):3415\u201325. https:\/\/doi.org\/10.1038\/s41388-018-0200-9.","journal-title":"Oncogene"},{"issue":"24","key":"2808_CR74","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1038\/emboj.2013.247","volume":"32","author":"J Niu","year":"2013","unstructured":"Niu J, Shi Y, Xue J, et al. USP10 inhibits genotoxic NF-\u03baB activation by MCPIP1-facilitated deubiquitination of NEMO. Embo J. 2013;32(24):3206\u201319. https:\/\/doi.org\/10.1038\/emboj.2013.247.","journal-title":"Embo J"},{"issue":"2","key":"2808_CR75","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.bbrc.2017.04.161","volume":"488","author":"X Xie","year":"2017","unstructured":"Xie X, Wang X, Jiang D, et al. PPPDE1 is a novel deubiquitinase belonging to a cysteine isopeptidase family. Biochem Biophys Res Commun. 2017;488(2):291\u201396.","journal-title":"Biochem Biophys Res Commun"},{"key":"2808_CR76","doi-asserted-by":"crossref","unstructured":"Mei H, Wen W, Zhang W, et al. Targeting DESI2 as a novel therapeutic strategy for JAK2-mutant leukemias. Adv Sci (Weinh). 2026;13(7):e15127.","DOI":"10.1002\/advs.202515127"},{"issue":"6","key":"2808_CR77","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S1097-2765(04)00157-1","volume":"13","author":"M Li","year":"2004","unstructured":"Li M, Brooks CL, Kon N, Gu W. A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol Cell. 2004;13(6):879\u201386. https:\/\/doi.org\/10.1016\/S1097-2765(04)00157-1.","journal-title":"Mol Cell"},{"issue":"1","key":"2808_CR78","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1042\/BST20230454","volume":"52","author":"DL Bolhuis","year":"2024","unstructured":"Bolhuis DL, Emanuele MJ, Brown NG. Friend or foe? Reciprocal regulation between E3 ubiquitin ligases and deubiquitinases. Biochem Soc Trans. 2024;52(1):241\u201367. https:\/\/doi.org\/10.1042\/BST20230454.","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"2808_CR79","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1038\/s41467-021-22024-3","volume":"12","author":"L Garcia-Martinez","year":"2021","unstructured":"Garcia-Martinez L, Zhang Y, Nakata Y, Chan HL, Morey L. Epigenetic mechanisms in breast cancer therapy and resistance. Nat Commun. 2021;12(1):1786. https:\/\/doi.org\/10.1038\/s41467-021-22024-3.","journal-title":"Nat Commun"},{"issue":"5","key":"2808_CR80","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.cmet.2019.03.009","volume":"29","author":"C Ling","year":"2019","unstructured":"Ling C, R\u00f6nn T. Epigenetics in human obesity and type 2 diabetes. Cell MetabCell Metab. 2019;29(5):1028\u201344. https:\/\/doi.org\/10.1016\/j.cmet.2019.03.009.","journal-title":"Cell MetabCell Metab"},{"key":"2808_CR81","doi-asserted-by":"publisher","unstructured":"Shu F, Xiao H, Li Q-N, Ren X-S, Liu Z-G, Hu B-W, et al. Epigenetic and post-translational modifications in autophagy: biological functions and therapeutic targets. Sig Transduct Target Ther. 2023;8(1). https:\/\/doi.org\/10.1038\/s41392-022-01300-8.","DOI":"10.1038\/s41392-022-01300-8"},{"issue":"7766","key":"2808_CR82","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/s41586-019-1411-0","volume":"571","author":"G Cavalli","year":"2019","unstructured":"Cavalli G, Heard E. Advances in epigenetics link genetics to the environment and disease. Nature. 2019;571(7766):489\u201399. https:\/\/doi.org\/10.1038\/s41586-019-1411-0.","journal-title":"Nature"},{"issue":"7","key":"2808_CR83","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.trecan.2020.02.003","volume":"6","author":"J Cao","year":"2020","unstructured":"Cao J, Yan Q. Cancer Epigenetics, tumor immunity, and immunotherapy. Trends Cancer. 2020;6(7):580\u201392. https:\/\/doi.org\/10.1016\/j.trecan.2020.02.003.","journal-title":"Trends Cancer"},{"issue":"1","key":"2808_CR84","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41392-023-01341-7","volume":"8","author":"N Wang","year":"2023","unstructured":"Wang N, Ma T, Yu B. Targeting epigenetic regulators to overcome drug resistance in cancers, signal transduct target ther. Signal Transduct Targeted Ther. 2023;8(1):69. https:\/\/doi.org\/10.1038\/s41392-023-01341-7.","journal-title":"Signal Transduct Targeted Ther"},{"key":"2808_CR85","doi-asserted-by":"publisher","unstructured":"Zhou S, Liu J, Wan A, Zhang Y, Qi X. Epigenetic regulation of diverse cell death modalities in cancer: a focus on pyroptosis, ferroptosis, cuproptosis, and disulfidptosis. J Hematol Oncol. 2024;17(1). https:\/\/doi.org\/10.1186\/s13045-024-01545-6.","DOI":"10.1186\/s13045-024-01545-6"},{"issue":"3","key":"2808_CR86","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2174\/0113892029296712240405053201","volume":"25","author":"R Mehmood","year":"2024","unstructured":"Mehmood R. Ramifications of m6A modification on ncRnas in cancer. Curr. Genomics. 2024;25(3):158\u201370. https:\/\/doi.org\/10.2174\/0113892029296712240405053201.","journal-title":"Curr. Genomics"},{"issue":"1","key":"2808_CR87","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s13046-024-03136-2","volume":"43","author":"X Tang","year":"2024","unstructured":"Tang X, et al. Examining the evidence for mutual modulation between m6A modification and circular RNAs: current knowledge and future prospects. J Exp Clin Cancer Res. 2024;43(1):216. https:\/\/doi.org\/10.1186\/s13046-024-03136-2.","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"2808_CR88","doi-asserted-by":"publisher","first-page":"101039","DOI":"10.1016\/j.gendis.2023.05.023","volume":"11","author":"W Li","year":"2024","unstructured":"Li W, Liu Y, Xu R, Zong Y, He L, Hu J, et al. M6A modification in cardiovascular disease: with a focus on programmed cell death. Genes Dis. 2024;11(5):101039. https:\/\/doi.org\/10.1016\/j.gendis.2023.05.023.","journal-title":"Genes Dis"},{"key":"2808_CR89","doi-asserted-by":"publisher","unstructured":"Liu WW, et al. RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy. Sig Transduct Target Ther. 2024;9(1). https:\/\/doi.org\/10.1038\/s41392-024-01777-5.","DOI":"10.1038\/s41392-024-01777-5"},{"issue":"1","key":"2808_CR90","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12943-022-01510-2","volume":"21","author":"LJ Deng","year":"2022","unstructured":"Deng LJ, Deng WQ, Fan SR, Chen MF, Qi M, Lyu WY, et al. m6A modification: recent advances, anticancer targeted drug discovery and beyond. Mol Cancer. 2022;21(1):52. https:\/\/doi.org\/10.1186\/s12943-022-01510-2.","journal-title":"Mol Cancer"},{"issue":"5","key":"2808_CR91","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrg3724","volume":"15","author":"Y Fu","year":"2014","unstructured":"Fu Y, Dominissini D, Rechavi G, He C. Gene expression regulation mediated through reversible m6A RNA methylation. Nat Rev Genet. 2014;15(5):293\u2013306. https:\/\/doi.org\/10.1038\/nrg3724.","journal-title":"Nat Rev Genet"},{"issue":"11","key":"2808_CR92","first-page":"1233","volume":"3","author":"JA Bokar","year":"1997","unstructured":"Bokar JA, Shambaugh ME, Polayes D, Matera AG, Rottman FM. Purification and cDNA cloning of the AdoMet-binding subunit of the human mRNA (N6-adenosine)-methyltransferase. RNA. 1997;3(11):1233\u201347.","journal-title":"RNA"},{"issue":"2","key":"2808_CR93","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.molcel.2016.05.041","volume":"63","author":"P Wang","year":"2016","unstructured":"Wang P, Doxtader KA, Nam Y. Structural basis for cooperative function of Mettl3 and Mettl14 methyltransferases. Mol Cell. 2016;63(2):306\u201317. https:\/\/doi.org\/10.1016\/j.molcel.2016.05.041.","journal-title":"Mol Cell"},{"issue":"7608","key":"2808_CR94","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nature18298","volume":"534","author":"X Wang","year":"2016","unstructured":"Wang X, et al. Structural basis of N6-adenosine methylation by the METTL3\u2013METTL14 complex. Nature. 2016;534(7608):575\u201378. https:\/\/doi.org\/10.1038\/nature18298.","journal-title":"Nature"},{"issue":"2","key":"2808_CR95","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nchembio.1432","volume":"10","author":"J Liu","year":"2014","unstructured":"Liu J, Yue Y, Han D, Wang X, Fu Y, Zhang L, et al. A METTL3\u2013METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol. 2014;10(2):93\u201395. https:\/\/doi.org\/10.1038\/nchembio.1432.","journal-title":"Nat Chem Biol"},{"issue":"2","key":"2808_CR96","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/cr.2014.3","volume":"24","author":"XL Ping","year":"2014","unstructured":"Ping XL, Sun BF, Wang L, et al. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res. 2014;24(2):177\u201389. https:\/\/doi.org\/10.1038\/cr.2014.3.","journal-title":"Cell Res"},{"issue":"1","key":"2808_CR97","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.celrep.2014.05.048","volume":"8","author":"S Schwartz","year":"2014","unstructured":"Schwartz S, Mumbach MR, Jovanovic M, Wang T, Maciag K, Bushkin GG, et al. Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5\u2032 sites. Cell Rep. 2014;8(1):284\u201396. https:\/\/doi.org\/10.1016\/j.celrep.2014.05.048.","journal-title":"Cell Rep"},{"key":"2808_CR98","doi-asserted-by":"publisher","unstructured":"Yue Y, Liu J, Cui X, Cao J, Luo G, Zhang Z, et al. VIRMA mediates preferential m6A mRNA methylation in 3\u2032UTR and near stop codon and associates with alternative polyadenylation. Cell Discov. 2018;4(1). https:\/\/doi.org\/10.1038\/s41421-018-0019-0.","DOI":"10.1038\/s41421-018-0019-0"},{"issue":"7620","key":"2808_CR99","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nature19342","volume":"537","author":"DP Patil","year":"2016","unstructured":"Patil DP, Chen CK, Pickering BF, Chow A, Jackson C, Guttman M, et al. m6A RNA methylation promotes XIST-mediated transcriptional repression. Nature. 2016;537(7620):369\u201373. https:\/\/doi.org\/10.1038\/nature19342.","journal-title":"Nature"},{"issue":"46","key":"2808_CR100","doi-asserted-by":"publisher","first-page":"33292","DOI":"10.1074\/jbc.M113.500397","volume":"288","author":"K Horiuchi","year":"2013","unstructured":"Horiuchi K, Kawamura T, Iwanari H, Ohashi R, Naito M, Kodama T, et al. Identification of Wilms\u2019 tumor 1-associating protein complex and its role in alternative splicing and the cell cycle. J Biol Chem. 2013;288(46):33292\u2013302. https:\/\/doi.org\/10.1074\/jbc.M113.500397.","journal-title":"J Biol Chem"},{"issue":"5","key":"2808_CR101","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.cell.2017.05.003","volume":"169","author":"KE Pendleton","year":"2017","unstructured":"Pendleton KE, Chen B, Liu K, Hunter OV, Xie Y, Tu BP, et al. The U6 snRNA m 6 a methyltransferase METTL16 regulates SAM synthetase intron retention. Cell. 2017;169(5):824\u201335.e14. https:\/\/doi.org\/10.1016\/j.cell.2017.05.003.","journal-title":"Cell"},{"key":"2808_CR102","doi-asserted-by":"publisher","unstructured":"Satterwhite ER, Mansfield KD. RNA methyltransferase METTL16: targets and function. Wiley Interdiscip Rev RNA. 2022;13(2):e 1681. https:\/\/doi.org\/10.1002\/wrna.1681.","DOI":"10.1002\/wrna.1681"},{"issue":"11","key":"2808_CR103","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.15252\/embr.201744940","volume":"18","author":"AS Warda","year":"2017","unstructured":"Warda AS, Kretschmer J, Hackert P, Lenz C, Urlaub H, H\u00f6bartner C, et al. Human METTL16 is a N6-methyladenosine (m6A) methyltransferase that targets pre-mRNAs and various non-coding RNAs. EMBO Rep. 2017;18(11):2004\u201314. https:\/\/doi.org\/10.15252\/embr.201744940.","journal-title":"EMBO Rep"},{"issue":"5\u20136","key":"2808_CR104","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1101\/gad.309146.117","volume":"32","author":"P Knuckles","year":"2018","unstructured":"Knuckles P, Lence T, Haussmann IU, Jacob D, Kreim N, Carl SH, et al. Zc3h13\/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15\/Spenito to the m 6 a machinery component Wtap\/Fl(2)d. Genes Dev. 2018;32(5\u20136):415\u201329. https:\/\/doi.org\/10.1101\/gad.309146.117.","journal-title":"Genes Dev"},{"issue":"6","key":"2808_CR105","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.molcel.2018.02.015","volume":"69","author":"J Wen","year":"2018","unstructured":"Wen J, Lv R, Ma H, Shen H, He C, Wang J, et al. Zc3h13 regulates nuclear RNA m6A methylation and mouse embryonic stem cell self-renewal. Mol Cell. 2018;69(6):1028\u201338.e6. https:\/\/doi.org\/10.1016\/j.molcel.2018.02.015.","journal-title":"Mol Cell"},{"issue":"15","key":"2808_CR106","doi-asserted-by":"publisher","first-page":"7719","DOI":"10.1093\/nar\/gkz619","volume":"47","author":"N van Tran","year":"2019","unstructured":"van Tran N, Ernst F, Hawley BR, Zorbas C, Ulryck N, Hackert P, et al. The human 18S rRNA m6A methyltransferase METTL5 is stabilized by TRMT112. Nucleic Acids Res. 2019;47(15):7719\u201333. https:\/\/doi.org\/10.1093\/nar\/gkz619.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2808_CR107","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41589-018-0184-3","volume":"15","author":"H Ma","year":"2019","unstructured":"Ma H, Wang X, Cai J, Dai Q, Natchiar SK, Lv R, et al. N6-methyladenosine methyltransferase ZCCHC4 mediates ribosomal RNA methylation. Nat Chem Biol. 2019;15(1):88\u201394. https:\/\/doi.org\/10.1038\/s41589-018-0184-3.","journal-title":"Nat Chem Biol"},{"issue":"2","key":"2808_CR108","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1093\/nar\/gkz1147","volume":"48","author":"R Pinto","year":"2020","unstructured":"Pinto R, V\u00e5gb\u00f8 CB, Jakobsson ME, Kim Y, Baltissen MP, O\u2019donohue MF, et al. The human methyltransferase ZCCHC4 catalyses N6-methyladenosine modification of 28S ribosomal RNA. Nucleic Acids Res. 2020;48(2):830\u201346. https:\/\/doi.org\/10.1093\/nar\/gkz1147.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2808_CR109","doi-asserted-by":"publisher","first-page":"5042","DOI":"10.1038\/s41467-019-12923-x","volume":"10","author":"W Ren","year":"2019","unstructured":"Ren W, Lu J, Huang M, Gao L, Li D, Wang GG, et al. Structure and regulation of ZCCHC4 in m6A-methylation of 28S rRNA. Nat Commun. 2019;10(1):5042. https:\/\/doi.org\/10.1038\/s41467-019-12923-x.","journal-title":"Nat Commun"},{"issue":"6","key":"2808_CR110","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41422-019-0270-4","volume":"30","author":"H Chen","year":"2020","unstructured":"Chen H, Gu L, Orellana EA, Wang Y, Guo J, Liu Q, et al. METTL4 is an snRNA m6Am methyltransferase that regulates RNA splicing. Cell Res. 2020;30(6):544\u201347. https:\/\/doi.org\/10.1038\/s41422-019-0270-4.","journal-title":"Cell Res"},{"issue":"12","key":"2808_CR111","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nchembio.687","volume":"7","author":"G Jia","year":"2011","unstructured":"Jia G, Fu Y, Zhao X, et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol. 2011;7(12):885\u201387. https:\/\/doi.org\/10.1038\/nchembio.687.","journal-title":"Nat Chem Biol"},{"issue":"1","key":"2808_CR112","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.molcel.2012.10.015","volume":"49","author":"G Zheng","year":"2013","unstructured":"Zheng G, Dahl JA, Niu Y, et al. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cell. 2013;49(1):18\u201329.","journal-title":"Mol Cell"},{"issue":"1","key":"2808_CR113","doi-asserted-by":"publisher","first-page":"42271","DOI":"10.1038\/srep42271","volume":"7","author":"Y Ueda","year":"2017","unstructured":"Ueda Y, Ooshio I, Fusamae Y, Kitae K, Kawaguchi M, Jingushi K, et al. AlkB homolog 3-mediated tRNA demethylation promotes protein synthesis in cancer cells. Sci Rep. 2017;7(1):42271. https:\/\/doi.org\/10.1038\/srep42271.","journal-title":"Sci Rep"},{"issue":"1","key":"2808_CR114","doi-asserted-by":"publisher","first-page":"12626","DOI":"10.1038\/ncomms12626","volume":"7","author":"H Du","year":"2016","unstructured":"Du H, Zhao Y, He J, Zhang Y, Xi H, Liu M, et al. YTHDF2 destabilizes m6A-containing RNA through direct recruitment of the CCR4\u2013NOT deadenylase complex. Nat Commun. 2016;7(1):12626. https:\/\/doi.org\/10.1038\/ncomms12626.","journal-title":"Nat Commun"},{"issue":"7481","key":"2808_CR115","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature12730","volume":"505","author":"X Wang","year":"2014","unstructured":"Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han D, et al. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature. 2014;505(7481):117\u201320. https:\/\/doi.org\/10.1038\/nature12730.","journal-title":"Nature"},{"issue":"6","key":"2808_CR116","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","volume":"161","author":"X Wang","year":"2015","unstructured":"Wang X, Zhao BS, Roundtree IA, Lu Z, Han D, Ma H, et al. N6-methyladenosine modulates messenger RNA translation efficiency. Cell. 2015;161(6):1388\u201399. https:\/\/doi.org\/10.1016\/j.cell.2015.05.014.","journal-title":"Cell"},{"key":"2808_CR117","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.cell.2015.10.012","volume":"163","author":"KD Meyer","year":"2015","unstructured":"Meyer KD, Patil DP, Zhou J, Zinoviev A, Skabkin MA, Elemento O, et al. 5\u2032 UTR m6A promotes cap-independent translation. Cell. 2015;163:999\u20131010. https:\/\/doi.org\/10.1016\/j.cell.2015.10.012.","journal-title":"Cell"},{"issue":"6","key":"2808_CR118","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.cell.2015.08.011","volume":"162","author":"CR Alarc\u00f3n","year":"2015","unstructured":"Alarc\u00f3n CR, Goodarzi H, Lee H, Liu X, Tavazoie S, Tavazoie SF. HNRNPA2B1 is a mediator of m6A-Dependent nuclear RNA processing events. Cell. 2015;162(6):1299\u2013308. https:\/\/doi.org\/10.1016\/j.cell.2015.08.011.","journal-title":"Cell"},{"issue":"7540","key":"2808_CR119","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/nature14234","volume":"518","author":"N Liu","year":"2015","unstructured":"Liu N, Dai Q, Zheng G, He C, Parisien M, Pan T. N6-methyladenosine-dependent RNA structural switches regulate RNA\u2013protein interactions. Nature. 2015;518(7540):560\u201364. https:\/\/doi.org\/10.1038\/nature14234.","journal-title":"Nature"},{"issue":"1","key":"2808_CR120","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41422-018-0113-8","volume":"29","author":"R Wu","year":"2019","unstructured":"Wu R, Li A, Sun B, Sun JG, Zhang J, Zhang T, et al. A novel m6A reader Prrc2a controls oligodendroglial specification and myelination. Cell Res. 2019;29(1):23\u201341. https:\/\/doi.org\/10.1038\/s41422-018-0113-8.","journal-title":"Cell Res"},{"issue":"10","key":"2808_CR121","doi-asserted-by":"publisher","first-page":"6051","DOI":"10.1093\/nar\/gkx141","volume":"45","author":"N Liu","year":"2017","unstructured":"Liu N, Zhou KI, Parisien M, Dai Q, Diatchenko L, Pan T. N 6-methyladenosine alters RNA structure to regulate binding of a low-complexity protein. Nucleic Acids Res. 2017;45(10):6051\u201363. https:\/\/doi.org\/10.1093\/nar\/gkx141.","journal-title":"Nucleic Acids Res"},{"key":"2808_CR122","doi-asserted-by":"publisher","unstructured":"Roundtree IA, Luo GZ, Zhang Z, Wang X, Zhou T, Cui Y, et al. YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs. Elife 6.eLife. 2017;6. https:\/\/doi.org\/10.7554\/eLife.31311.","DOI":"10.7554\/eLife.31311"},{"issue":"4","key":"2808_CR123","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.molcel.2016.01.012","volume":"61","author":"W Xiao","year":"2016","unstructured":"Xiao W, Adhikari S, Dahal U, Chen YS, Hao YJ, Sun BF, et al. Nuclear m6A Reader YTHDC1 regulates mRNA splicing. Mol Cell. 2016;61(4):507\u201319. https:\/\/doi.org\/10.1016\/j.molcel.2016.01.012.","journal-title":"Mol Cell"},{"issue":"3","key":"2808_CR124","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/cr.2017.10","volume":"27","author":"A Li","year":"2017","unstructured":"Li A, Chen YS, Ping XL, Yang X, Xiao W, Yang Y, et al. Cytoplasmic m6A reader YTHDF3 promotes mRNA translation. Cell Res. 2017;27(3):444\u201347. https:\/\/doi.org\/10.1038\/cr.2017.10.","journal-title":"Cell Res"},{"issue":"3","key":"2808_CR125","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/cr.2017.15","volume":"27","author":"H Shi","year":"2017","unstructured":"Shi H, Wang X, Lu Z, Zhao BS, Ma H, Hsu PJ, et al. YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA. Cell Res. 2017;27(3):315\u201328. https:\/\/doi.org\/10.1038\/cr.2017.15.","journal-title":"Cell Res"},{"issue":"9","key":"2808_CR126","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/cr.2017.99","volume":"27","author":"PJ Hsu","year":"2017","unstructured":"Hsu PJ, Zhu Y, Ma H, Guo Y, Shi X, Liu Y, et al. Ythdc2 is an N6-methyladenosine binding protein that regulates mammalian spermatogenesis. Cell Res. 2017;27(9):1115\u201327. https:\/\/doi.org\/10.1038\/cr.2017.99.","journal-title":"Cell Res"},{"issue":"3","key":"2808_CR127","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","volume":"20","author":"H Huang","year":"2018","unstructured":"Huang H, Weng H, Sun W, Qin X, Shi H, Wu H, et al. Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol. 2018;20(3):285\u201395. https:\/\/doi.org\/10.1038\/s41556-018-0045-z.","journal-title":"Nat Cell Biol"},{"issue":"4","key":"2808_CR128","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.celrep.2019.06.072","volume":"28","author":"BM Edens","year":"2019","unstructured":"Edens BM, Vissers C, Su J, Arumugam S, Xu Z, Shi H, et al. FMRP modulates neural differentiation through m6A-Dependent mRNA nuclear export. Cell Rep. 2019;28(4):845\u201354.e5. https:\/\/doi.org\/10.1016\/j.celrep.2019.06.072.","journal-title":"Cell Rep"},{"key":"2808_CR129","doi-asserted-by":"publisher","first-page":"3936","DOI":"10.1093\/hmg\/ddy292","volume":"27","author":"F Zhang","year":"2018","unstructured":"Zhang F, Kang Y, Wang M, Li Y, Xu T, Yang W, et al. Fragile X mental retardation protein modulates the stability of its m6A-marked messenger RNA targets. Hum Mol Genet. 2018;27:3936\u201350. https:\/\/doi.org\/10.1093\/hmg\/ddy292.","journal-title":"Hum Mol Genet"},{"issue":"12","key":"2808_CR130","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1016\/j.molcel.2023.05.010","volume":"83","author":"F Yu","year":"2023","unstructured":"Yu F, Zhu AC, Liu S, Gao B, Wang Y, Khudaverdyan N, et al. RBM33 is a unique m6A RNA-binding protein that regulates ALKBH5 demethylase activity and substrate selectivity. Mol Cell. 2023;83(12):2003\u201319.e6. https:\/\/doi.org\/10.1016\/j.molcel.2023.05.010.","journal-title":"Mol Cell"},{"issue":"26","key":"2808_CR131","doi-asserted-by":"publisher","first-page":"17697","DOI":"10.1016\/S0021-9258(17)32497-3","volume":"269","author":"JA Bokar","year":"1994","unstructured":"Bokar JA, Rath-Shambaugh ME, Ludwiczak R, Narayan P, Rottman F. Characterization and partial purification of mRNA N6-adenosine methyltransferase from HeLa cell nuclei. Internal mRNA methylation requires a multisubunit complex. J Biol Chem. 1994;269(26):17697\u2013704. https:\/\/doi.org\/10.1016\/S0021-9258(17)32497-3.","journal-title":"J Biol Chem"},{"issue":"2","key":"2808_CR132","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/ncb2902","volume":"16","author":"Y Wang","year":"2014","unstructured":"Wang Y, Li Y, Toth JI, Petroski MD, Zhang Z, Zhao JC. N6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells. Nat Cell Biol. 2014;16(2):191\u201398. https:\/\/doi.org\/10.1038\/ncb2902.","journal-title":"Nat Cell Biol"},{"issue":"7632","key":"2808_CR133","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nature20568","volume":"540","author":"T Lence","year":"2016","unstructured":"Lence T, Akhtar J, Bayer M, Schmid K, Spindler L, Ho CH, et al. m6A modulates neuronal functions and sex determination in Drosophila. Nature. 2016;540(7632):242\u201347. https:\/\/doi.org\/10.1038\/nature20568.","journal-title":"Nature"},{"issue":"14","key":"2808_CR134","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.1073\/pnas.1720945115","volume":"115","author":"J Guo","year":"2018","unstructured":"Guo J, Tang HW, Li J, Perrimon N, Yan D. Xio is a component of the drosophila sex determination pathway and RNA N 6 -methyladenosine methyltransferase complex. Proc Natl Acad Sci USA. 2018;115(14):3674\u201379. https:\/\/doi.org\/10.1073\/pnas.1720945115.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"2808_CR135","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1016\/j.celrep.2017.11.092","volume":"21","author":"H Shima","year":"2017","unstructured":"Shima H, Matsumoto M, Ishigami Y, Ebina M, Muto A, Sato Y, et al. S-Adenosylmethionine synthesis is regulated by selective N6-adenosine methylation and mRNA degradation involving METTL16 and YTHDC1. Cell Rep. 2017;21(12):3354\u201363. https:\/\/doi.org\/10.1016\/j.celrep.2017.11.092.","journal-title":"Cell Rep"},{"issue":"3","key":"2808_CR136","doi-asserted-by":"publisher","first-page":"101590","DOI":"10.1016\/j.jbc.2022.101590","volume":"298","author":"C Sepich-Poore","year":"2022","unstructured":"Sepich-Poore C, Zheng Z, Schmitt E, Wen K, Zhang ZS, Cui XL, et al. The METTL5-TRMT112 N6-methyladenosine methyltransferase complex regulates mRNA translation via 18S rRNA methylation. J Biol Chem. 2022;298(3):101590. https:\/\/doi.org\/10.1016\/j.jbc.2022.101590.","journal-title":"J Biol Chem"},{"key":"2808_CR137","doi-asserted-by":"publisher","first-page":"9250","DOI":"10.1093\/nar\/gkaa684","volume":"48","author":"YT Goh","year":"2020","unstructured":"Goh YT, Koh C, Sim DY, Roca X, Goh W. METTL4 catalyzes m6Am methylation in U2 snRNA to regulate pre-mRNA splicing. Nucleic Acids Res. 2020;48:9250\u201361. https:\/\/doi.org\/10.1093\/nar\/gkaa684.","journal-title":"Nucleic Acids Res"},{"issue":"7637","key":"2808_CR138","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature21022","volume":"541","author":"J Mauer","year":"2017","unstructured":"Mauer J, Luo X, Blanjoie A, Jiao X, Grozhik AV, Patil DP, et al. Reversible methylation of m6Am in the 5\u2032 cap controls mRNA stability. Nature. 2017;541(7637):371\u201375. https:\/\/doi.org\/10.1038\/nature21022.","journal-title":"Nature"},{"issue":"10","key":"2808_CR139","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","volume":"20","author":"S Zaccara","year":"2019","unstructured":"Zaccara S, Ries RJ, Jaffrey SR. Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol. 2019;20(10):608\u201324. https:\/\/doi.org\/10.1038\/s41580-019-0168-5.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7397","key":"2808_CR140","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nature11112","volume":"485","author":"D Dominissini","year":"2012","unstructured":"Dominissini D, Moshitch-Moshkovitz S, Schwartz S, et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature. 2012;485(7397):201\u201306. https:\/\/doi.org\/10.1038\/nature11112.","journal-title":"Nature"},{"issue":"1","key":"2808_CR141","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z, et al. The role of m6A modification in the biological functions and diseases. Sig Transduct Target Ther. 2021;6(1):74. https:\/\/doi.org\/10.1038\/s41392-020-00450-x.","journal-title":"Sig Transduct Target Ther"},{"issue":"7724","key":"2808_CR142","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41586-018-0538-8","volume":"561","author":"J Choe","year":"2018","unstructured":"Choe J, Lin S, Zhang W, Liu Q, Wang L, Ramirez-Moya J, et al. mRNA circularization by METTL3\u2013eIf3h enhances translation and promotes oncogenesis. Nature. 2018;561(7724):556\u201360. https:\/\/doi.org\/10.1038\/s41586-018-0538-8.","journal-title":"Nature"},{"key":"2808_CR143","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nature14281","volume":"519","author":"CR Alarc\u00f3n","year":"2015","unstructured":"Alarc\u00f3n CR, Lee H, Goodarzi H, Halberg N, Tavazoie SF. N6-methyladenosine marks primary microRNAs for processing. Nature. 2015;519:482\u201385. https:\/\/doi.org\/10.1038\/nature14281.","journal-title":"Nature"},{"key":"2808_CR144","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/nature08697","volume":"463","author":"CJ David","year":"2010","unstructured":"David CJ, Chen M, Assanah M, Canoll P, Manley JL. HnRNP proteins controlled by c-myc deregulate pyruvate kinase mRNA splicing in cancer. Nature. 2010;463:364\u201368. https:\/\/doi.org\/10.1038\/nature08697.","journal-title":"Nature"},{"issue":"7","key":"2808_CR145","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/nsmb.1838","volume":"17","author":"J K\u00f6nig","year":"2010","unstructured":"K\u00f6nig J, Zarnack K, Rot G, Curk T, Kayikci M, Zupan B, et al. iCLIP reveals the function of hnRNP particles in splicing at individual nucleotide resolution. Nat Struct Mol Biol. 2010;17(7):909\u201315. https:\/\/doi.org\/10.1038\/nsmb.1838.","journal-title":"Nat Struct Mol Biol"},{"issue":"1","key":"2808_CR146","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13046-025-03272-3","volume":"44","author":"H Wang","year":"2025","unstructured":"Wang H, Cui C, Li W, Wu H, Sha J, Pan J, et al. AGD1\/USP10\/METTL13 complexes enhance cancer stem cells proliferation and diminish the therapeutic effect of docetaxel via CD44 m6A modification in castration resistant prostate cancer. J Exp Clin Cancer Res. 2025;44(1):12. https:\/\/doi.org\/10.1186\/s13046-025-03272-3.","journal-title":"J Exp Clin Cancer Res"},{"issue":"12","key":"2808_CR147","doi-asserted-by":"publisher","first-page":"113918","DOI":"10.1016\/j.isci.2025.113918","volume":"28","author":"B Zhang","year":"2025","unstructured":"Zhang B, Han W, Gao X, Li W, Yu J, Zhao W, et al. USP25 deubiquitinates cytosolic METTL3 to impede glioma proliferation via an m6A-independent pathway. iScience. 2025;28(12):113918. https:\/\/doi.org\/10.1016\/j.isci.2025.113918.","journal-title":"iScience"},{"issue":"3","key":"2808_CR148","doi-asserted-by":"publisher","first-page":"483","DOI":"10.17305\/bjbms.2022.7930","volume":"23","author":"J Li","year":"2023","unstructured":"Li J, Yang J, Chen Z, Liu L, Wang H, Deng Q, et al. Promotive role of USP29-mediated deubiquitination in malignant proliferation of colorectal cancer cells via the KIAA1429\/SOX8 axis. Biomol Biomed. 2023;23(3):483\u201395. https:\/\/doi.org\/10.17305\/bjbms.2022.7930.","journal-title":"Biomol Biomed"},{"key":"2808_CR149","doi-asserted-by":"publisher","unstructured":"Hao YH, Yang CR, Shi WJ, Zhong XY. PSMD14 transcriptionally activated by MEF2A promotes pancreatic cancer development by upregulating SPON2 expression. Kaohsiung J Med Scie. 2025;41(5):e70007. https:\/\/doi.org\/10.1002\/kjm2.70007.","DOI":"10.1002\/kjm2.70007"},{"issue":"1","key":"2808_CR150","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s10020-025-01285-4","volume":"31","author":"Q Wang","year":"2025","unstructured":"Wang Q, Wei D, Li C, Yang X, Su K, Wang T, et al. O-GlcNAcylation with ubiquitination stabilizes METTL3 to promoting HMGB1 degradation to inhibit ferroptosis and enhance gemcitabine resistance in pancreatic cancer. Mol Med. 2025;31(1):228. https:\/\/doi.org\/10.1186\/s10020-025-01285-4.","journal-title":"Mol Med"},{"issue":"6","key":"2808_CR151","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.7150\/thno.103629","volume":"15","author":"X Zhou","year":"2025","unstructured":"Zhou X, Xia Q, Wang B, Li J, Liu B, Wang S, et al. USP14 modulates stem-like properties, tumorigenicity, and radiotherapy resistance in glioblastoma stem cells through stabilization of MST4-phosphorylated ALKBH5. Theranostics. 2025;15(6):2293\u2013314. https:\/\/doi.org\/10.7150\/thno.103629.","journal-title":"Theranostics"},{"issue":"3","key":"2808_CR152","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.18632\/aging.202359","volume":"13","author":"W Song","year":"2021","unstructured":"Song W, Yang K, Luo J, Gao Z, Gao Y. Dysregulation of USP18\/FTO\/PYCR1 signaling network promotes bladder cancer development and progression. Aging (Albany NY). 2021;13(3):3909\u201325. https:\/\/doi.org\/10.18632\/aging.202359.","journal-title":"Aging (Albany NY)"},{"issue":"8","key":"2808_CR153","doi-asserted-by":"publisher","first-page":"105055","DOI":"10.1016\/j.jbc.2023.105055","volume":"299","author":"P Wang","year":"2023","unstructured":"Wang P, Wang J, Yao S, Cui M, Cheng Y, Liu W, et al. Deubiquitinase USP9X stabilizes RNA m6A demethylase ALKBH5 and promotes acute myeloid leukemia cell survival. J Biol Chem. 2023;299(8):105055. https:\/\/doi.org\/10.1016\/j.jbc.2023.105055.","journal-title":"J Biol Chem"},{"issue":"11","key":"2808_CR154","doi-asserted-by":"publisher","first-page":"116476","DOI":"10.1016\/j.celrep.2025.116476","volume":"44","author":"F Ge","year":"2025","unstructured":"Ge F, Zhu H, Liu X, Li Y, Guo R, Zeng C, et al. IGF2BP2 stabilized by USP7 promotes cancer-associated fibroblast activation and attenuates gemcitabine sensitivity in PDAC. Cell Rep. 2025;44(11):116476. https:\/\/doi.org\/10.1016\/j.celrep.2025.116476.","journal-title":"Cell Rep"},{"issue":"2","key":"2808_CR155","doi-asserted-by":"publisher","first-page":"449","DOI":"10.7150\/ijbs.76798","volume":"19","author":"J Shi","year":"2023","unstructured":"Shi J, Zhang Q, Yin X, Ye J, Gao S, Chen C, et al. Stabilization of IGF2BP1 by USP10 promotes breast cancer metastasis via CPT1A in an m6A-dependent manner. Int J Biol Sci. 2023;19(2):449\u201364. https:\/\/doi.org\/10.7150\/ijbs.76798.","journal-title":"Int J Biol Sci"},{"issue":"3","key":"2808_CR156","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41388-025-03654-z","volume":"45","author":"YL Liang","year":"2025","unstructured":"Liang YL, Zhong CR, Wu JY, Lin ZJ, Lin Z, Yi TJ, et al. USP10 promotes cell proliferation and gemcitabine resistance in pancreatic cancer by the regulation of IGF2BP3-STEAP3. Oncogene. 2025;45(3):383\u201397. https:\/\/doi.org\/10.1038\/s41388-025-03654-z.","journal-title":"Oncogene"},{"key":"2808_CR157","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1038\/s41388-025-03425-w","volume":"44","author":"L You","year":"2025","unstructured":"You L, Wang Q, Zhang T, Xiao H, Lv M, Lv H, et al. USP14-IMP2-CXCL2 axis in tumor-associated macrophages facilitates resistance to anti-PD-1 therapy in gastric cancer by recruiting myeloid-derived suppressor cells. Oncogene. 2025;44:2413\u201326. https:\/\/doi.org\/10.1038\/s41388-025-03425-w.","journal-title":"Oncogene"},{"key":"2808_CR158","doi-asserted-by":"publisher","unstructured":"Wang A, Huang H, Shi JH, Yu X, Ding R, Zhang Y, et al. USP47 inhibits m6A-dependent c-myc translation to maintain regulatory T cell metabolic and functional homeostasis. J Clin Invest. 2023;133(23):e169365. https:\/\/doi.org\/10.1172\/JCI169365.","DOI":"10.1172\/JCI169365"},{"issue":"1","key":"2808_CR159","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41419-025-08038-5","volume":"16","author":"T Xia","year":"2025","unstructured":"Xia T, Zhao J, Zhang Z, Lu W, Wang Y, Dong X, et al. The deubiquitinase USP9X and E3 ligase WWP1 orchestrate IGF2BP2 ubiquitination homeostasis to drive TNBC progression and cisplatin sensitivity. Cell Death Dis. 2025;16(1):703. https:\/\/doi.org\/10.1038\/s41419-025-08038-5.","journal-title":"Cell Death Dis"},{"key":"2808_CR160","doi-asserted-by":"publisher","first-page":"107152","DOI":"10.1016\/j.jbc.2024.107152","volume":"300","author":"X Zhao","year":"2024","unstructured":"Zhao X, Lv S, Li N, Zou Q, Sun L, Song T. YTHDF2 protein stabilization by the deubiquitinase OTUB1 promotes prostate cancer cell proliferation via PRSS8 mRNA degradation. J Biol Chem. 2024;300:107152. https:\/\/doi.org\/10.1016\/j.jbc.2024.107152.","journal-title":"J Biol Chem"},{"key":"2808_CR161","doi-asserted-by":"publisher","unstructured":"Yu Y, Hu J, Wang W, Lei H, Xi Z, Zhang P, et al. Targeting PSMD14 combined with arachidonic acid induces synthetic lethality via FADS1 m 6 a modification in triple-negative breast cancer. Sci Adv. 2025;11(19):eadr 3173. https:\/\/doi.org\/10.1126\/sciadv.adr3173.","DOI":"10.1126\/sciadv.adr3173"},{"issue":"1","key":"2808_CR162","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41420-024-01893-9","volume":"10","author":"Z Yang","year":"2024","unstructured":"Yang Z, Yu W, Xu A, Liu B, Jin L, Tao H, et al. mTORC1 accelerates osteosarcoma progression via m6A-dependent stabilization of USP7 mRNA. Cell Death Discov. 2024;10(1):127. https:\/\/doi.org\/10.1038\/s41420-024-01893-9.","journal-title":"Cell Death Discov"},{"issue":"1","key":"2808_CR163","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s10238-025-01814-9","volume":"25","author":"P Zhu","year":"2025","unstructured":"Zhu P, Li H, Ge J, Zhou Z, Chen D, Li Q. Mechanism of USP11 regulated SIRT3\/ROS in drug resistance of acute myeloid leukemia. Clin Exp Med. 2025;25(1):267. https:\/\/doi.org\/10.1007\/s10238-025-01814-9.","journal-title":"Clin Exp Med"},{"issue":"2","key":"2808_CR164","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41418-022-01107-8","volume":"30","author":"Z Gao","year":"2023","unstructured":"Gao Z, Li C, Sun H, Bian Y, Cui Z, Wang N, et al. N6-methyladenosine-modified USP13 induces pro-survival autophagy and imatinib resistance via regulating the stabilization of autophagy-related protein 5 in gastrointestinal stromal tumors. Cell Death Differ. 2023;30(2):544\u201359. https:\/\/doi.org\/10.1038\/s41418-022-01107-8.","journal-title":"Cell Death Differ"},{"issue":"1","key":"2808_CR165","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41420-024-02282-y","volume":"11","author":"R Fang","year":"2025","unstructured":"Fang R, Jia Z, Xin Y, Zhao K, Qin W, Lu H, et al. N6-methyladenosine-modification of USP15 regulates chemotherapy resistance by inhibiting LGALS3 ubiquitin-mediated degradation via AKT\/mTOR signaling activation pathway in hepatocellular carcinoma. Cell Death Discov. 2025;11(1):3. https:\/\/doi.org\/10.1038\/s41420-024-02282-y.","journal-title":"Cell Death Discov"},{"key":"2808_CR166","doi-asserted-by":"publisher","unstructured":"Zhang X, Chen X, Qian F, Zhu Y, He G, Yang J, et al. Deubiquitinase USP19 modulates apoptotic calcium release and endoplasmic reticulum stress by deubiquitinating BAG6 in triple negative breast cancer. Clin Transl Med. 2023;13(9):e 1398. https:\/\/doi.org\/10.1002\/ctm2.1398.","DOI":"10.1002\/ctm2.1398"},{"issue":"6","key":"2808_CR167","doi-asserted-by":"publisher","first-page":"5462","DOI":"10.1007\/s10528-024-10992-2","volume":"63","author":"P Yao","year":"2025","unstructured":"Yao P, Li X, Chai J, Dong J, Chen Y, Zhang T, et al. METTL3-mediated m6A methylation of USP21 contributes to hepatocellular carcinoma progression by stabilizing H2BFS through deubiquitination. Biochem Genet. 2025;63(6):5462\u201379. https:\/\/doi.org\/10.1007\/s10528-024-10992-2.","journal-title":"Biochem Genet"},{"key":"2808_CR168","doi-asserted-by":"publisher","first-page":"107509","DOI":"10.1016\/j.phrs.2024.107509","volume":"210","author":"X Zhuang","year":"2024","unstructured":"Zhuang X, Yin S, Cheng J, Sun W, Fang Z, Xiang Y, et al. METTL14-mediated m6A modification enhances USP22-ER\u03b1 axis to drive breast cancer malignancy. Pharmacol Res. 2024;210:107509. https:\/\/doi.org\/10.1016\/j.phrs.2024.107509.","journal-title":"Pharmacol Res"},{"key":"2808_CR169","doi-asserted-by":"publisher","unstructured":"He L, Li X, Zhen Y, He J, Wang C. METTL3\/IGF2BP3 axis promotes gemcitabine resistance of pancreatic cancer cells through regulating USP33-mediated PAK1 deubiquitination and degradation. Naunyn-Schmiedeberg's Arch Pharmacol. 2026;399(3):4341\u201356. https:\/\/doi.org\/10.1007\/s00210-025-04575-0.","DOI":"10.1007\/s00210-025-04575-0"},{"issue":"7","key":"2808_CR170","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1158\/1078-0432.CCR-23-2357","volume":"30","author":"S Guan","year":"2024","unstructured":"Guan S, Chen X, Wei Y, Wang F, Xie W, Chen Y, et al. Germline USP36 mutation confers resistance to EGFR-TKIs by upregulating MLLT3 expression in patients with non\u2013small cell lung cancer. Clin Cancer Res. 2024;30(7):1382\u201396. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-2357.","journal-title":"Clin Cancer Res"},{"key":"2808_CR171","doi-asserted-by":"publisher","unstructured":"Huang J, Zhou W, Hao C, He Q, Tu X. The feedback loop of METTL14 and USP38 regulates cell migration, invasion and EMT as well as metastasis in bladder cancer. PLoS Genet. 2022;18(10):e1010366. https:\/\/doi.org\/10.1371\/journal.pgen.1010366.","DOI":"10.1371\/journal.pgen.1010366"},{"issue":"14","key":"2808_CR172","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1158\/0008-5472.CAN-20-4163","volume":"81","author":"L Du","year":"2021","unstructured":"Du L, Li Y, Kang M, Feng M, Ren Y, Dai H, et al. USP48 is upregulated by Mettl14 to attenuate hepatocellular carcinoma via regulating SIRT6 stabilization. Cancer Res. 2021;81(14):3822\u201334. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-4163.","journal-title":"Cancer Res"},{"issue":"9","key":"2808_CR173","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1002\/tox.23852","volume":"38","author":"Y Song","year":"2023","unstructured":"Song Y, Wu Q. RBM15 m 6 a modification-mediated OTUB2 upregulation promotes cervical cancer progression via the AKT \/ mTOR signaling. Environ Toxicol. 2023;38(9):2155\u201364. https:\/\/doi.org\/10.1002\/tox.23852.","journal-title":"Environ Toxicol"},{"issue":"2","key":"2808_CR174","doi-asserted-by":"publisher","first-page":"113353","DOI":"10.1016\/j.yexcr.2022.113353","volume":"420","author":"C Zhang","year":"2022","unstructured":"Zhang C, Wan J, Liu Q, Long F, Wen Z, Liu Y. METTL3 upregulates COPS5 expression in osteosarcoma in an m6A-related manner to promote osteosarcoma progression. Exp Cell Res. 2022;420(2):113353. https:\/\/doi.org\/10.1016\/j.yexcr.2022.113353.","journal-title":"Exp Cell Res"},{"issue":"6","key":"2808_CR175","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s13577-025-01274-z","volume":"38","author":"Q Su","year":"2025","unstructured":"Su Q, Liu W, Wang P, Wang M. Long non-coding RNA FEZF1-AS1 suppresses ferroptosis in multiple myeloma cells through KIAA1429-mediated m6A modification. Hum Cell. 2025;38(6):178. https:\/\/doi.org\/10.1007\/s13577-025-01274-z.","journal-title":"Hum Cell"},{"issue":"1","key":"2808_CR176","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41419-025-07657-2","volume":"16","author":"X Zhao","year":"2025","unstructured":"Zhao X, Li Y, Zhang H, Cai Y, Wang X, Liu Y, et al. PAK5 promotes the trastuzumab resistance by increasing HER2 nuclear accumulation in HER2-positive breast cancer. Cell Death Dis. 2025;16(1):323. https:\/\/doi.org\/10.1038\/s41419-025-07657-2.","journal-title":"Cell Death Dis"},{"key":"2808_CR177","doi-asserted-by":"publisher","first-page":"217770","DOI":"10.1016\/j.canlet.2025.217770","volume":"625","author":"J Shan","year":"2025","unstructured":"Shan J, Chen Z, Chen M, Wu Z, Zhu H, Jin X, et al. SENP3 induced HADHA deSumoylation enhances intrahepatic cholangiocarcinoma chemotherapy sensitivity via fatty acid oxidation. Cancer Lett. 2025;625:217770. https:\/\/doi.org\/10.1016\/j.canlet.2025.217770.","journal-title":"Cancer Lett"},{"key":"2808_CR178","doi-asserted-by":"publisher","first-page":"112244","DOI":"10.1016\/j.cellsig.2025.112244","volume":"138","author":"C Ma","year":"2026","unstructured":"Ma C, Wang D, Gao W, Wang X, Xu X, Jia J, et al. METTL3-mediated m6A modification of circCDYL promotes gastric cancer progression by acting as miR-378a-5p sponge to regulate USP13 expression. Cell Signal. 2026;138:112244. https:\/\/doi.org\/10.1016\/j.cellsig.2025.112244.","journal-title":"Cell Signal"},{"issue":"6","key":"2808_CR179","doi-asserted-by":"publisher","first-page":"304","DOI":"10.21037\/atm-22-556","volume":"10","author":"X Ye","year":"2022","unstructured":"Ye X, Wang LP, Han C, Hu H, Ni CM, Qiao GL, et al. Increased m6A modification of lncRNA DBH-AS1 suppresses pancreatic cancer growth and gemcitabine resistance via the miR-3163\/USP44 axis. Ann Transl Med. 2022;10(6):304. https:\/\/doi.org\/10.21037\/atm-22-556.","journal-title":"Ann Transl Med"},{"issue":"1","key":"2808_CR180","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12943-021-01398-4","volume":"20","author":"Z Liu","year":"2021","unstructured":"Liu Z, Wang T, She Y, Wu K, Gu S, Li L, et al. N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer. Mol Cancer. 2021;20(1):105. https:\/\/doi.org\/10.1186\/s12943-021-01398-4.","journal-title":"Mol Cancer"},{"issue":"9","key":"2808_CR181","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/mc.23330","volume":"60","author":"H Gong","year":"2021","unstructured":"Gong H, Liu L, Cui L, Ma H, Shen L. ALKBH5-mediated m6A-demethylation of USP1 regulated T-cell acute lymphoblastic leukemia cell glucocorticoid resistance by Aurora B. Mol Carcinog. 2021;60(9):644\u201357. https:\/\/doi.org\/10.1002\/mc.23330.","journal-title":"Mol Carcinog"},{"issue":"3","key":"2808_CR182","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.bbrc.2019.03.093","volume":"512","author":"J Li","year":"2019","unstructured":"Li J, Han Y, Zhang H, Qian Z, Jia W, Gao Y, et al. The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA. Biochem Biophys Res Commun. 2019;512(3):479\u201385. https:\/\/doi.org\/10.1016\/j.bbrc.2019.03.093.","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"2808_CR183","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1158\/0008-5472.CAN-21-2106","volume":"82","author":"P Yadav","year":"2022","unstructured":"Yadav P, Subbarayalu P, Medina D, Nirzhor S, Timilsina S, Rajamanickam S, et al. M6A RNA methylation regulates histone ubiquitination to support cancer growth and progression. Cancer Res. 2022;82(10):1872\u201389. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-2106.","journal-title":"Cancer Res"},{"key":"2808_CR184","doi-asserted-by":"publisher","first-page":"101576","DOI":"10.1016\/j.tranon.2022.101576","volume":"27","author":"WM Huang","year":"2023","unstructured":"Huang WM, Li ZX, Wu YH, Shi ZL, Mi JL, Hu K, et al. m6A demethylase FTO renders radioresistance of nasopharyngeal carcinoma via promoting OTUB1-mediated anti-ferroptosis. Transl Oncol. 2023;27:101576. https:\/\/doi.org\/10.1016\/j.tranon.2022.101576.","journal-title":"Transl Oncol"},{"issue":"1","key":"2808_CR185","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12943-024-02223-4","volume":"24","author":"Z Zheng","year":"2025","unstructured":"Zheng Z, Lin F, Zhao B, Chen G, Wei C, Chen X, et al. ALKBH5 suppresses gastric cancer tumorigenesis and metastasis by inhibiting the translation of uncapped WRAP53 RNA isoforms in an m6A-dependent manner. Mol Cancer. 2025;24(1):19. https:\/\/doi.org\/10.1186\/s12943-024-02223-4.","journal-title":"Mol Cancer"},{"key":"2808_CR186","doi-asserted-by":"publisher","unstructured":"Zhang P, Ma L, Wei Y, Peng Q, Xiang H, Fang X, et al. DAZAP1 promotes cancer progression and chemotherapy resistance by stabilizing PIN1 protein in gastric cancer. Cell Biol Toxicol. 2025;42(1). https:\/\/doi.org\/10.1007\/s10565-025-10118-3.","DOI":"10.1007\/s10565-025-10118-3"},{"key":"2808_CR187","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.omtn.2021.08.019","volume":"26","author":"B Yue","year":"2021","unstructured":"Yue B, Cui R, Zheng R, Jin W, Song C, Bao T, et al. Essential role of ALKBH5-mediated RNA demethylation modification in bile acid-induced gastric intestinal metaplasia. Mol Ther Nucleic Acids. 2021;26:458\u201372. https:\/\/doi.org\/10.1016\/j.omtn.2021.08.019.","journal-title":"Mol Ther Nucleic Acids"},{"key":"2808_CR188","doi-asserted-by":"publisher","unstructured":"Chen Y, Wang YL, Qiu K, Cao YQ, Zhang FJ, Zhao HB, et al. YTHDF2 promotes temozolomide resistance in glioblastoma by activation of the akt and NF-\u03baB signalling pathways via inhibiting EPHB3 and TNFAIP3. Clin Trans Imm. 2022;11(5):e 1393. https:\/\/doi.org\/10.1002\/cti2.1393.","DOI":"10.1002\/cti2.1393"},{"issue":"10","key":"2808_CR189","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.7150\/ijbs.58514","volume":"17","author":"J Wang","year":"2021","unstructured":"Wang J, Tan L, Jia B, Yu X, Yao R, Ouyang N, et al. Downregulation of m 6 a Reader YTHDC2 promotes the proliferation and migration of malignant lung cells via CYLD\/NF-\u03baB pathway. Int J Biol Sci. 2021;17(10):2633\u201351. https:\/\/doi.org\/10.7150\/ijbs.58514.","journal-title":"Int J Biol Sci"},{"key":"2808_CR190","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.freeradbiomed.2025.02.025","volume":"231","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Zhou D, Qiu X, Xia F, Li X. N6-methyladenosine-mediated EIF3H promotes anaplastic thyroid cancer progression and ferroptosis resistance by stabilizing \u03b2-catenin. Free Radic Biol Med. 2025;231:38\u201347. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2025.02.025.","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"2808_CR191","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1002\/kjm2.12902","volume":"40","author":"L Li","year":"2024","unstructured":"Li L, Yang N, Sun JH, Wei LJ, Gao Y. IGF2BP3-dependent N6-methyladenosine modification of USP49 promotes carboplatin resistance in retinoblastoma by enhancing autophagy via regulating the stabilization of SIRT1. The Kaohsiung J Med Sci. 2024;40(12):1043\u201356. https:\/\/doi.org\/10.1002\/kjm2.12902.","journal-title":"The Kaohsiung J Med Sci"},{"issue":"12","key":"2808_CR192","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1016\/j.molcel.2025.05.015","volume":"85","author":"T Liu","year":"2025","unstructured":"Liu T, Yang D, Wei Q, Wang Y, Tian L, Liu X, et al. The RNA-stability-independent role of the RNA m6A reader YTHDF2 in promoting protein translation to confer tumor chemotherapy resistance. Mol Cell. 2025;85(12):2320\u201336.e9. https:\/\/doi.org\/10.1016\/j.molcel.2025.05.015.","journal-title":"Mol Cell"},{"key":"2808_CR193","doi-asserted-by":"publisher","unstructured":"Li Y, He X, Lu X, Gong Z, Li Q, Zhang L, et al. METTL3 acetylation impedes cancer metastasis via fine-tuning its nuclear and cytosolic functions. Nat Commun. 2022;13(1): 6350. https:\/\/doi.org\/10.1038\/s41467-022-34209-5.","DOI":"10.1038\/s41467-022-34209-5"},{"issue":"1","key":"2808_CR194","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12964-023-01148-7","volume":"21","author":"B Liu","year":"2023","unstructured":"Liu B, Cao J, Wu B, Hao K, Wang X, Chen X, et al. METTL3 and STAT3 form a positive feedback loop to promote cell metastasis in hepatocellular carcinoma. Cell Commun Signal. 2023;21(1):21. https:\/\/doi.org\/10.1186\/s12964-023-01148-7.","journal-title":"Cell Commun Signal"},{"issue":"8","key":"2808_CR195","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1080\/15384101.2023.2170521","volume":"22","author":"CJ Chen","year":"2023","unstructured":"Chen CJ, Huang JY, Huang JQ, Deng JY, Shangguan XH, Chen AZ, et al. Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4. Cell Cycle. 2023;22(8):986\u20131004. https:\/\/doi.org\/10.1080\/15384101.2023.2170521.","journal-title":"Cell Cycle"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-026-02808-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02808-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02808-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:51:50Z","timestamp":1792097510000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-026-02808-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":195,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2808"],"URL":"https:\/\/doi.org\/10.1186\/s12943-026-02808-1","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]},"assertion":[{"value":"21 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All of the authors are aware of and agree to the content of the paper and their being listed as a co-author of the paper.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"241"}}